Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH - CEPHALON -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (16)	10/31/2002 4:29:03 PM
From: Icebrg	Read Replies (1) \| Respond to of 109

RESEARCH ALERT- JP Morgan starts Cephalon as 'neutral' Thursday October 31, 11:58 am ET NEW YORK, Oct 31 (Reuters) - JP Morgan analyst Corey Davis started started the drugmaker Cephalon with a "neutral" rating on Thursday. "We believe Cephalon, with 3 products on the market that are still very early in their life cycles, is a relatively low-risk story, with several years of 40% earnings growth to come," Davis said in a note to clients. Comment: I wonder what their BUYs look like.